Literature DB >> 22428726

Antioxidant status in hyperthyroid cats before and after radioiodine treatment.

E Branter1, N Drescher, M Padilla, L A Trepanier.   

Abstract

BACKGROUND: Reversible antioxidant depletion is found in hyperthyroid humans, and antioxidant depletion increases the risk of methimazole toxicosis in rats.
OBJECTIVES: To determine whether abnormalities in concentrations of blood antioxidants or urinary isoprostanes were present in hyperthyroid cats, and were reversible after radioiodine treatment. To determine whether or not antioxidant abnormalities were associated with idiosyncratic methimazole toxicosis. ANIMALS: Hyperthyroid cats presented for radioiodine treatment (n = 44) and healthy mature adult control cats (n = 37).
METHODS: Prospective, controlled, observational study. Red blood cell glutathione (GSH), plasma ascorbate (AA), plasma free retinol (vitamin A), α-tocopherol (vitamin E), and urinary free 8-isoprostanes in hyperthyroid cats were compared to healthy cats and to hyperthyroid cats 2 months after treatment.
RESULTS: Blood antioxidants were not significantly different in hyperthyroid cats (mean GSH 1.6 ± 0.3 mM; AA 12.8 ± 4.9 μM, and vitamin E, 25 ± 14 μg/mL) compared to controls (GSH 1.4 ± 0.4 mM; AA 15.0 ± 6.6 μM, and vitamin E, 25 ± 17 μg/mL). Urinary isoprostanes were increased in hyperthyroid cats (292 ± 211 pg/mg creatinine) compared to controls (169 ± 82 pg/mg; P = .006), particularly in hyperthyroid cats with a USG < 1.035. Plasma free vitamin A was higher in hyperthyroid cats (0.54 ± 0.28 μg/mL versus 0.38 ± 0.21 in controls; P = .007). Both abnormalities normalized after radioiodine treatment. No association was found between oxidative status and prior idiosyncratic methimazole toxicosis. CONCLUSION AND CLINICAL IMPORTANCE: Increased urinary isoprostane could reflect reversible renal oxidative stress induced by hyperthyroidism, and this requires additional evaluation.
Copyright © 2012 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22428726     DOI: 10.1111/j.1939-1676.2012.00903.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  6 in total

1.  Feline urinary F2-isoprostanes measured by enzyme-linked immunoassay and gas chromatography-mass spectroscopy are poorly correlated.

Authors:  Andrew D Woolcock; Ashley Leisering; Pierre Deshuillers; Janet Roque-Torres; George E Moore
Journal:  J Vet Diagn Invest       Date:  2020-07-05       Impact factor: 1.279

Review 2.  The role of thyroid hormones as inductors of oxidative stress and neurodegeneration.

Authors:  I Villanueva; C Alva-Sánchez; J Pacheco-Rosado
Journal:  Oxid Med Cell Longev       Date:  2013-12-09       Impact factor: 6.543

3.  Urinary F2 -Isoprostanes in Cats with International Renal Interest Society Stage 1-4 Chronic Kidney Disease.

Authors:  W Whitehouse; J Quimby; S Wan; K Monaghan; R Robbins; L A Trepanier
Journal:  J Vet Intern Med       Date:  2017-02-04       Impact factor: 3.333

4.  Redox unbalance in the hyperthyroid cat: a comparison with healthy and non-thyroidal diseased cats.

Authors:  Alessia Candellone; Paola Gianella; Lara Ceccarelli; Graziella Raviri; Paola Badino; Silvia Roncone; Hans S Kooistra; Giorgia Meineri
Journal:  BMC Vet Res       Date:  2019-05-08       Impact factor: 2.741

5.  Evaluation of Antioxidant Supplementation on Redox Unbalance in Hyperthyroid Cats Treated with Methimazole: A Blinded Randomized Controlled Trial.

Authors:  Alessia Candellone; Paola Badino; Paola Gianella; Flavia Girolami; Graziella Raviri; Vittorio Saettone; Giorgia Meineri
Journal:  Antioxidants (Basel)       Date:  2019-12-23

Review 6.  Renal biomarkers in cats: A review of the current status in chronic kidney disease.

Authors:  Thirawut Kongtasai; Dominique Paepe; Evelyne Meyer; Femke Mortier; Sofie Marynissen; Lisa Stammeleer; Pieter Defauw; Sylvie Daminet
Journal:  J Vet Intern Med       Date:  2022-02-26       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.